You searched for "medication"
PPPD - the problem with the label
The recently described diagnostic entity of persistent postural perceptual dizziness (PPPD) has its merits regarding guiding intervention and treatment, but the label itself can be problematic for patients. This study was designed to determine the views of patients of the...XXXVIII Congreso Panamericano ORL
The 38th PanAmerican meeting will be full of innovative lectures and sunny afternoons. It launches with three pre-meeting workshops on 15 June: cochlear implants, in conjunction with the International Federation of Otolaryngology Societies (IFOS); Botox injections and facial contouring; and...What’s new about the 5th Congress of the CEORL-HNS?
The CEORL-HNS congress will feature novel ideas for sessions, including debates, ‘basic ENT’ and ‘nightmare’ sessions! The two leading figures of the meeting tell us about the evolution of the congress and future directions. There is something new about the...Giacomo Puccini’s laryngeal cancer
Giacomo Puccini, one of the best known composers of all time, was diagnosed with laryngeal cancer and died from the disease in 1924. In this article, Rosario Marchese-Ragona and Alessandro Martini describe Puccini’s experience of the disease with quotes from...
Small vestibular schwannomas (VS) – is waiting the right thing to do?
VS management can be surgical, by radiosurgery or watchful waiting. Middle fossa approach (MCF) can be implemented in small and some medium-size tumours, and has the potential to preserve hearing. The authors measured quality of life of VS patients who...Combined use of a hearing aid and a cochlear implant: a case study
When multi-channel cochlear implants (CIs) were first introduced in the 1980s, their use was restricted to people who derived no benefit from conventional amplification. Over the past three decades, however, the criteria for CIs has been relaxed considerably, and it...Access to and uptake of cochlear implants in the UK
Assessing demands on cochlear implant (CI) services is very important for both commissioners and clinicians in anticipating clinical need and funding requirements. Commercial CI’s were introduced in the late 1980s. Initial funding was from charitable sources. The first major advance...
Cochlear implantation in immunosuppressed patients. Is it feasible?
The effectiveness of cochlear implantation has led to a relaxation of the candidate criteria. Patients who had been rejected in the past may now be accepted and their outcomes are encouraging. However, the acceptance of immunosuppressed patients as cochlear implant...
